• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用经典眼睑清洁措施并联合或不联合额外脂质替代以稳定泪膜治疗睑板腺功能障碍

Treatment of Meibomian Gland Dysfunction by Classical Eyelid Hygiene Measures With and Without Additional Lipid Substitution for Tear Film Stabilization.

作者信息

Weinstein Isabel, Kelava Augustin, Dausch Dieter, Seitz Berthold

机构信息

Department of Ophthalmology (I.W., B.S.), Saarland University Medical Center (UKS), Homburg/Saar, Germany; Methods Center (A.K.), Eberhard Karls University Tübingen, Germany; and Praxis Prof. Dr. Dieter Dausch (D.D.), Amberg, Germany.

出版信息

Eye Contact Lens. 2025 Mar 1;51(3):e123-e128. doi: 10.1097/ICL.0000000000001155. Epub 2024 Dec 10.

DOI:10.1097/ICL.0000000000001155
PMID:39661458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11850009/
Abstract

OBJECTIVE

This study aimed to document the treatment success of eyelid hygiene with liposomal suspension using new diagnostic tools and to determine whether additional lipid substitution provided measurable benefits in meibomian gland dysfunction.

METHODS

A single-center controlled, partially single masked study was conducted. Group A used eyelid hygiene only, whereas group B additionally applied a liposomal eye spray. Subjective perception using the Ocular Surface Disease Index (OSDI) questionnaire, measurement of tear film osmolarity, noninvasive tear film break-up time, assessment of the lipid layer, meibography, inspection of lid margins, assessment of the meibomian glands, and measurement of matrix-metallopeptidase-9 were collected at baseline and after 12 weeks.

RESULTS

Eighty-two patients were included and randomized into two groups. Both groups showed a decrease in OSDI score ( P <0.001), an increase in lipid layer thickness ( P <0.001), significant improvement in the degree of loss of meibomian glands ( P <0.001), in the damage pattern of the eyelid margins ( P <0.001), in the quality of meibomian gland secretion, and in matrix-metallopeptidase-9 after 12 weeks.

CONCLUSIONS

Our study confirms the success of treatment with eyelid hygiene measures using a liposomal suspension. The additional benefit of lipid substitution was not significant after 12 weeks of treatment.

摘要

目的

本研究旨在利用新的诊断工具记录脂质体混悬液进行眼睑清洁治疗的成功率,并确定额外的脂质替代疗法在睑板腺功能障碍中是否能带来可测量的益处。

方法

开展了一项单中心对照、部分单盲研究。A组仅采用眼睑清洁,而B组额外使用脂质体眼喷雾。在基线期和12周后收集使用眼表疾病指数(OSDI)问卷的主观感受、泪膜渗透压测量、非侵入性泪膜破裂时间、脂质层评估、睑板腺造影、睑缘检查、睑板腺评估以及基质金属蛋白酶-9的测量结果。

结果

纳入82例患者并随机分为两组。两组在12周后OSDI评分均降低(P<0.001),脂质层厚度增加(P<0.001),睑板腺缺失程度、睑缘损伤模式、睑板腺分泌质量以及基质金属蛋白酶-9均有显著改善(P<0.001)。

结论

我们的研究证实了使用脂质体混悬液的眼睑清洁措施治疗的成功。治疗12周后,脂质替代疗法的额外益处并不显著。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b53/11850009/2be945f30bbb/ecl-51-e123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b53/11850009/95677049534a/ecl-51-e123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b53/11850009/2be945f30bbb/ecl-51-e123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b53/11850009/95677049534a/ecl-51-e123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b53/11850009/2be945f30bbb/ecl-51-e123-g002.jpg

相似文献

1
Treatment of Meibomian Gland Dysfunction by Classical Eyelid Hygiene Measures With and Without Additional Lipid Substitution for Tear Film Stabilization.采用经典眼睑清洁措施并联合或不联合额外脂质替代以稳定泪膜治疗睑板腺功能障碍
Eye Contact Lens. 2025 Mar 1;51(3):e123-e128. doi: 10.1097/ICL.0000000000001155. Epub 2024 Dec 10.
2
Tear film lipid layer thickness measurement from Ocular Surface Analyzer as a marker to monitor treatment of meibomian gland dysfunction in a study comparing physiological detergent-free eyelid wipes with conventional therapy: A randomized trial.使用眼前部分析仪测量泪膜脂质层厚度作为监测治疗睑板腺功能障碍的指标:一项比较生理性无清洁剂眼睑擦拭与常规治疗的随机试验。
Indian J Ophthalmol. 2022 Jun;70(6):1963-1970. doi: 10.4103/ijo.IJO_2885_21.
3
Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction.强脉冲光治疗联合睑板腺按摩治疗中重度睑板腺功能障碍
Clin Exp Optom. 2018 Jan;101(1):23-33. doi: 10.1111/cxo.12541. Epub 2017 Jun 6.
4
Efficacy and safety of intense pulsed light of upper and lower eyelids in Meibomian gland dysfunction: A prospective multicentric study.强脉冲光治疗上下眼睑睑板腺功能障碍的疗效和安全性:一项前瞻性多中心研究。
Eur J Ophthalmol. 2024 May;34(3):700-707. doi: 10.1177/11206721231199121. Epub 2023 Sep 6.
5
Meibum Expressibility Improvement as a Therapeutic Target of Intense Pulsed Light Treatment in Meibomian Gland Dysfunction and Its Association with Tear Inflammatory Cytokines.强脉冲光治疗睑板腺功能障碍中改善睑脂排出作为治疗靶点及其与泪液炎症细胞因子的相关性。
Sci Rep. 2019 May 21;9(1):7648. doi: 10.1038/s41598-019-44000-0.
6
Efficacy and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction-A Randomized, Double-Masked, Sham-Controlled Clinical Trial.强脉冲光治疗睑板腺功能障碍患者的疗效和安全性:一项随机、双盲、假对照临床试验。
Cornea. 2020 Mar;39(3):325-332. doi: 10.1097/ICO.0000000000002204.
7
Different Number of Sessions of Intense Pulsed Light and Meibomian Gland Expression Combination Therapy for Meibomian Gland Dysfunction.不同次数强脉冲光联合睑板腺按摩治疗睑板腺功能障碍。
Korean J Ophthalmol. 2022 Dec;36(6):527-542. doi: 10.3341/kjo.2022.0068. Epub 2022 Oct 25.
8
Changes in the distribution of the tear film lipid layer after intensive pulsed light combined with meibomian gland expression in patients with meibomian gland dysfunction.睑板腺功能障碍患者接受强脉冲光联合睑板腺按摩后泪膜脂质层分布的变化
PLoS One. 2025 Feb 28;20(2):e0316935. doi: 10.1371/journal.pone.0316935. eCollection 2025.
9
Mechanical meibomian gland squeezing combined with eyelid scrubs and warm compresses for the treatment of meibomian gland dysfunction.睑板腺机械挤压联合眼睑擦洗及热敷治疗睑板腺功能障碍。
Clin Exp Optom. 2017 Nov;100(6):598-602. doi: 10.1111/cxo.12532. Epub 2017 Mar 12.
10
The Effect of Therapeutic Meibomian Glands Expression on Evaporative Dry Eye: A Prospective Randomized Controlled Trial.睑板腺按摩治疗蒸发过强型干眼的效果:一项前瞻性随机对照试验
Curr Eye Res. 2021 Feb;46(2):195-201. doi: 10.1080/02713683.2020.1789663. Epub 2020 Aug 25.

本文引用的文献

1
Latest developments in meibography: A review.最新的眼瞼摄影术发展:综述。
Ocul Surf. 2022 Jul;25:119-128. doi: 10.1016/j.jtos.2022.06.002. Epub 2022 Jun 18.
2
Effect of Eye Spray Phospholipid Concentration on the Tear Film and Ocular Comfort.眼用制剂磷脂浓度对泪膜和眼舒适的影响。
Eye Contact Lens. 2021 Aug 1;47(8):445-448. doi: 10.1097/ICL.0000000000000788.
3
Visible Meibomian Gland Structure Increases After Vectored Thermal Pulsation Treatment in Dry Eye Disease Patients with Meibomian Gland Dysfunction.睑板腺功能障碍的干眼症患者经矢量热脉动治疗后,可见睑板腺结构增加。
Clin Ophthalmol. 2020 Dec 7;14:4287-4296. doi: 10.2147/OPTH.S282081. eCollection 2020.
4
Prospective randomized study to evaluate the efficacy and tolerability of Ectoin® containing Eye Spray (EES09) and comparison to the liposomal Eye Spray Tears Again® (TA) in the treatment of dry eye disease.前瞻性随机研究评估含依克多因的眼用喷雾(EES09)的疗效和耐受性,并与脂质体眼用喷雾 Tears Again®(TA)治疗干眼症进行比较。
Cont Lens Anterior Eye. 2021 Jun;44(3):101318. doi: 10.1016/j.clae.2020.04.003. Epub 2020 Apr 27.
5
[Diagnosis of dry eye disease].[干眼症的诊断]
Ophthalmologe. 2018 May;115(5):433-450. doi: 10.1007/s00347-018-0676-2.
6
Comparison of treatment effect across varying severities of meibomian gland dropout.比较不同严重程度的睑板腺缺失的治疗效果。
Cont Lens Anterior Eye. 2018 Feb;41(1):88-92. doi: 10.1016/j.clae.2017.09.004. Epub 2017 Sep 30.
7
TFOS DEWS II Management and Therapy Report.TFOS DEWS II 管理和治疗报告。
Ocul Surf. 2017 Jul;15(3):575-628. doi: 10.1016/j.jtos.2017.05.006. Epub 2017 Jul 20.
8
TFOS DEWS II Diagnostic Methodology report.TFOS DEWS II 诊断方法学报告。
Ocul Surf. 2017 Jul;15(3):539-574. doi: 10.1016/j.jtos.2017.05.001. Epub 2017 Jul 20.
9
TFOS DEWS II Definition and Classification Report.TFOS DEWS II 定义与分类报告。
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
10
Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye.眼表炎症的存在与否指导着干眼症的临床和治疗管理。
Clin Ophthalmol. 2016 Nov 24;10:2337-2343. doi: 10.2147/OPTH.S121256. eCollection 2016.